Medical devices, healthcare technology and the business of care
DEVICE CATEGORY · NCD

Test, Immunity, Cell Mediated, Mycobacterium Tuberculosis

FDA classification: Unknown. Device class 3.

Product / regulatory recordCompanyPathwayDecision dateSource
QiagenPMA supplementOct 14, 2026FDA
DiaSorin, Inc.PMA supplementSep 24, 2026FDA
DiaSorin, Inc.PMA supplementAug 27, 2026FDA
DiaSorin, Inc.PMA supplementAug 27, 2026FDA
DiaSorin, Inc.PMA supplementMay 26, 2026FDA
DiaSorin, Inc.PMA supplementJan 26, 2026FDA
QiagenPMA supplementJan 23, 2026FDA
DiaSorin, Inc.PMA supplementDec 19, 2025FDA
QiagenPMA supplementNov 21, 2025FDA
DiaSorin, Inc.PMA supplementOct 10, 2025FDA
DiaSorin, Inc.PMA supplementAug 28, 2025FDA
DiaSorin, Inc.PMA supplementAug 21, 2025FDA
DiaSorin, Inc.PMA approvalNov 26, 2019FDA
QiagenPMA approvalNov 28, 2001FDA
Source information

Follow the FDA links to view the original records.

All device categories